Virginia Retirement Systems’s Corcept Therapeutics CORT Stock Holding History

Virginia Retirement Systems’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.19M	Sell	18,974 -7,600	-29%	-$817K	0.01%	516
2026 Q2	$2.31M	Buy	26,574 +16,000	+151%	+$966K	0.01%	507
2026 Q1	$426K	Sell	10,574 -800	-7%	-$29.9K	﹤0.01%	795
2025 Q4	$396K	Sell	11,374 -4,800	-30%	-$377K	﹤0.01%	800
2025 Q3	$1.34M	Sell	16,174 -400	-2%	-$28.9K	0.01%	505
2025 Q2	$1.22M	Sell	16,574 -100	-0.6%	-$7.25K	0.01%	531
2025 Q1	$1.9M	Buy	+16,674	New	+$1.01M	0.01%	381
2023 Q3	$1.61M	Sell	59,000 -5,200	-8%	-$150K	0.02%	386
2023 Q2	$1.43M	Sell	64,200 -900	-1%	-$20.7K	0.01%	443
2023 Q1	$1.41M	Buy	65,100 +16,600	+34%	+$364K	0.01%	441
2022 Q4	$985K	Buy	48,500 +4,100	+9%	+$103K	0.01%	611
2022 Q3	$1.14M	Buy	+44,400	New	+$1.19M	0.01%	532
2022 Q1	$1.37M	Sell	60,700 -7,500	-11%	-$160K	0.01%	539
2021 Q4	$1.35M	Sell	68,200 -1,100	-2%	-$22.3K	0.01%	552
2021 Q3	$1.36M	Buy	69,300 +18,800	+37%	+$393K	0.01%	529
2021 Q2	$1.11M	Buy	50,500 +2,200	+5%	+$49K	0.01%	610
2021 Q1	$1.15M	Buy	48,300 +6,200	+15%	+$166K	0.01%	604
2020 Q4	$1.1M	Sell	42,100 -7,600	-15%	-$160K	0.01%	573
2020 Q3	$865K	Sell	49,700 -19,300	-28%	-$308K	0.01%	582
2020 Q2	$1.16M	Sell	69,000 -11,500	-14%	-$162K	0.01%	515
2020 Q1	$957K	Buy	80,500 +8,000	+11%	+$99K	0.01%	572
2019 Q4	$877K	Sell	72,500 -20,000	-22%	-$278K	0.01%	742
2019 Q3	$1.31M	Sell	92,500 -8,700	-9%	-$107K	0.01%	580
2019 Q2	$1.13M	Sell	101,200 -19,700	-16%	-$220K	0.01%	634
2019 Q1	$1.42M	Buy	120,900 +48,300	+67%	+$600K	0.02%	536
2018 Q4	$970K	Buy	72,600 +58,800	+426%	+$777K	0.01%	629
2018 Q3	$193K	Sell	13,800 -63,900	-82%	-$893K	﹤0.01%	1020
2018 Q2	$1.22M	Sell	77,700 -6,500	-8%	-$113K	0.02%	624
2018 Q1	$1.38M	Sell	84,200 -12,300	-13%	-$228K	0.02%	555
2017 Q4	$1.74M	Sell	96,500 -12,000	-11%	-$217K	0.02%	516
2017 Q3	$2.09M	Buy	108,500 +97,700	+905%	+$1.46M	0.03%	486
2017 Q2	$127K	Buy	+10,800	New	+$117K	﹤0.01%	1024

Other funds holding CORT

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Virginia Retirement Systems's CORT Position: Q3 2026 in Review

Virginia Retirement Systems reduced its Corcept Therapeutics (CORT) stake by 29% in Q3 2026, selling an estimated $817K and leaving 18,974 shares worth $2.19M. The position accounts for 0.01% of the portfolio, ranked #516.

Virginia Retirement Systems first reported a position in CORT in Q2 2017 and has held it in 32 quarters since. The position peaked at $2.31M in Q2 2026. 280 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Virginia Retirement Systems held 18,974 shares of Corcept Therapeutics worth $2.19M as of Q3 2026.
Virginia Retirement Systems sold 7,600 Corcept Therapeutics shares in Q3 2026, an estimated $817K.
Corcept Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #516 holding.
Virginia Retirement Systems first reported a position in Corcept Therapeutics in Q2 2017 and has held it in 32 quarters since.
Virginia Retirement Systems's Corcept Therapeutics position peaked at $2.31M in Q2 2026.
280 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.